Fingerprint
Dive into the research topics where Walter Hanel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexate
Arnold, Z. J., Lundberg, J., Wiczer, T., Handley, D., Bond, D., Sawalha, Y., Sigmund, A., Reneau, J., Hanel, W., Sharp, J., Youssef, Y., Alinari, L., Brammer, J., Christian, B. A., Baiocchi, R., Maddocks, K., Epperla, N. & Voorhees, T. J., 2026, (Accepted/In press) In: Journal of Oncology Pharmacy Practice.Research output: Contribution to journal › Article › peer-review
-
Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with relapsed/refractory large B-cell lymphoma
Sharp, J., Zhao, Q., Voorhees, T. J., Bond, D. A., Sawalha, Y., Reneau, J., Sigmund, A., Hanel, W., Sehgal, L., Alinari, L., Baiocchi, R., Brammer, J. E., Maddocks, K., Christian, B., Bezerra, E., Denlinger, N., Vasu, S., De Lima, M., Prosek, J. & Epperla, N., Sep 2025, In: British Journal of Haematology. 207, 3, p. 992-1001 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Hepatosplenic T-Cell Lymphoma
Hanel, W., Jul 15 2025, Handbook of Hematologic Malignancies: Third Edition. Springer Publishing Company, p. 491-500 10 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma
Chowdhury, S. M., Bhatta, S., Voorhees, T. J., Annunzio, K., Bond, D. A., Sawalha, Y., Sigmund, A., Hanel, W., Sehgal, L., Alinari, L., Baiocchi, R., Maddocks, K., Christian, B., Jones, D. & Epperla, N., Dec 2025, In: Journal of Hematology and Oncology. 18, 1, 4.Research output: Contribution to journal › Letter › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Phase I/II Study of Subasumstat (TAK-981) in Combination With Rituximab in Relapsed/Refractory Non-Hodgkin Lymphoma
Assouline, S. E., Mehta, A., Hanel, W., Doucet, S., Johnston, P. B., Danilov, A. V., Cooper, B. W., Chudnovsky, A., Ding, J., Long, T., Stroopinsky, D., Berg, D. & Alinari, L., Nov 2025, In: Clinical Lymphoma, Myeloma and Leukemia. 25, 11, p. 788-799.e11Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations